Buprenorphine HCl and Naloxone HCl

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 50268-145
  • Package NDC 50268-145-15
  • Application number ANDA203136
  • SPL ID 47e23f4e-d4aa-7af1-e063-6394a90a2f05
  • SPL set ID b955054b-b37d-4079-4fed-5939b763ecb4
  • UNII 5Q187997EE
  • UNII 56W8MW3EN1
  • RxCUI 351266
  • RxCUI 351267

What the source publishes

Labeler
AvPAK
Active ingredients
Buprenorphine and Naloxone
Form
TABLET
Routes
SUBLINGUAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:50268-145_47e23f4e-d4aa-7af1-e063-6394a90a2f05
{
  "name": "Buprenorphine HCl and Naloxone HCl",
  "splId": "47e23f4e-d4aa-7af1-e063-6394a90a2f05",
  "labels": [
    {
      "setId": "b955054b-b37d-4079-4fed-5939b763ecb4",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b955054b-b37d-4079-4fed-5939b763ecb4",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b955054b-b37d-4079-4fed-5939b763ecb4"
    }
  ],
  "routes": [
    "SUBLINGUAL"
  ],
  "labeler": "AvPAK",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-145-15)  / 1 TABLET in 1 BLISTER PACK (50268-145-11)",
      "package_ndc": "50268-145-15",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20161208"
    }
  ],
  "productId": "50268-145_47e23f4e-d4aa-7af1-e063-6394a90a2f05",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "50268-145",
  "deaSchedule": "CIII",
  "genericName": "Buprenorphine and Naloxone",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BUPRENORPHINE HYDROCHLORIDE",
      "strength": "8 mg/1"
    },
    {
      "name": "NALOXONE HYDROCHLORIDE DIHYDRATE",
      "strength": "2 mg/1"
    }
  ],
  "applicationNumber": "ANDA203136",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20161208",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "5Q187997EE",
      "56W8MW3EN1"
    ],
    "rxcui": [
      "351266",
      "351267"
    ],
    "spl_set_id": [
      "b955054b-b37d-4079-4fed-5939b763ecb4"
    ],
    "manufacturer_name": [
      "AvPAK"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:50268-145_47e23f4e-d4aa-7af1-e063-6394a90a2f05"